Shang‐Yi Lin
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
-
- Antibiotic Use and Resistance
Papers in
-
- Antifungal resistance and susceptibility 9
- Antimicrobial Resistance in Staphylococcus 6
- Epidemiology 16
- Pneumonia and Respiratory Infections 4
- Mycobacterium research and diagnosis 4
- Co-authors
- Yen‐Hsu Chen (21 shared papers)Ya-Ting Chang (7 shared papers)Po‐Ren Hsueh (5 shared papers)Chau‐Chyun Sheu (2 shared papers)Po‐Liang Lu (36 shared papers)Tun‐Chieh Chen (22 shared papers)Anne Chao (1 shared paper)Bryan Finegan (1 shared paper)
- Journals
- Journal of Microbiology Immunology and Infection (13 papers)Mycoses (2 papers)Journal of Antimicrobial Chemotherapy (2 papers)BMC Infectious Diseases (2 papers)Antimicrobial Agents and Chemotherapy (2 papers)
- Partner nations
- TaiwanThailandUnited States
In The Last Decade
Shang‐Yi Lin
60 papers receiving 1.2k citations
Shang‐Yi Lin's Hit Papers
Peers
Comparison fields: 5 of 125
- Molecular Medicine 363
- Applied Microbiology and Biotechnology 112
- Endocrinology 118
- Clinical Biochemistry 96
- Infectious Diseases 242
Countries citing papers authored by Shang‐Yi Lin
This map shows the geographic impact of Shang‐Yi Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shang‐Yi Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shang‐Yi Lin more than expected).
Fields of papers citing papers by Shang‐Yi Lin
This network shows the impact of papers produced by Shang‐Yi Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shang‐Yi Lin. The network helps show where Shang‐Yi Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Shang‐Yi Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Infections Caused by Carbapenem-Resistant Enterobacteriaceae: An Update on Therapeutic Options Hit paper breakdown → | 2019 | 396 |
| 2 | 2011 | 213 | |
| 3 | 2016 | 59 | |
| 4 | 2018 | 40 | |
| 5 | 2019 | 40 | |
| 6 | 2020 | 32 | |
| 7 | 2018 | 29 | |
| 8 | 2019 | 28 | |
| 9 | 2012 | 27 | |
| 10 | 1998 | 26 | |
| 11 | 2018 | 24 | |
| 12 | 2022 | 22 | |
| 13 | 2023 | 20 | |
| 14 | 2020 | 18 | |
| 15 | 2018 | 17 | |
| 16 | 2008 | 14 | |
| 17 | 2012 | 13 | |
| 18 | 2022 | 13 | |
| 19 | 2020 | 11 | |
| 20 | 2012 | 10 |
About Shang‐Yi Lin
Shang‐Yi Lin is a scholar working on Infectious Diseases, Epidemiology, Molecular Medicine, Pharmacology and Clinical Biochemistry, having authored 63 papers that have together received 1.2k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (11 papers), Antifungal resistance and susceptibility (9 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers), Antimicrobial Resistance in Staphylococcus (6 papers), Bacterial Identification and Susceptibility Testing (5 papers), Pneumonia and Respiratory Infections (4 papers), Mycobacterium research and diagnosis (4 papers) and Infections and bacterial resistance (4 papers). The work is most often cited by research in Molecular Medicine (363 citations), Applied Microbiology and Biotechnology (112 citations), Endocrinology (118 citations), Clinical Biochemistry (96 citations) and Infectious Diseases (242 citations). Shang‐Yi Lin has collaborated with scholars based in Taiwan, Thailand and United States. Frequent co-authors include Yen‐Hsu Chen, Ya-Ting Chang, Po‐Ren Hsueh, Chau‐Chyun Sheu, Po‐Liang Lu, Tun‐Chieh Chen, Anne Chao, Bryan Finegan, Susan G. Letcher and Robin L. Chazdon. Their work appears in journals such as Journal of Microbiology Immunology and Infection, Mycoses, Journal of Antimicrobial Chemotherapy, BMC Infectious Diseases and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.